StemCells (STEM) Posts Q3 Loss of $0.31, Sales Top Expectations
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.31), $0.14 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $224 thousand versus the consensus estimate of $210 thousand.